Type-2 Diabetes Clinical Trial
Official title:
A Mediterranean-pattern Meal Increases GLP-1 and Oxyntomodulin More Than an Energy-matched High Fiber Plant-Based Meal in Type 2 Diabetes Patients: A Randomized Clinical Trial Assessment Through the Visual Analogue Scale.
The aim of this trial was to assess glycemic control and incretin release in subjects
affected by type-2 diabetes, a condition in which GLP-1 release is impaired. It is known that
nutrition affects a variety of factors in overall quality of life in diabetes and we
hypothesized incretin secretion may improve in acute. As little is known regarding
oxyntomodulin secretion in relation to diet, we explored this gut-derived hormone behavior as
well.
Hence, the administration of two meals was carried out; these were equal in terms of calories
but different for macronutrients composition. Appetite rating was assessed as well through a
100-mm horizontal Visual Analogue Scale, either at fasting and for 4 hours once the meal was
completed.
Type-2 diabetes (T2D) is a multifactorial metabolic burden whose metabolic features include
alterations in GLP-1 secretion and ultimately hunger/satiety circuit derangement.
Manipulating the composition of the diet in order to promote GLP-1 secretion may represent a
promising lifestyle strategy for obesity and T2D management.
The objective of this study was to assess the post-prandial profile of appetite- regulating
hormones and assessing the post-prandial appetite ratings using a Visual Analogue Scale
(VAS), as well as measuring the fasting and postprandial glucose/insulin responses in
overweight and/or obese, well controlled patients with T2D.
Twelve T2D patients (M:F = 7:5) aged 63.1±8.5 years were enrolled in a randomized,
controlled, crossover trial. Subjects consumed on two different days, at one-week interval,
an experimental High Fiber Vegetarian meal (HFV) rich in dietary carbohydrate and fiber in
comparison with a standard, Mediterranean-like meal (MED). The two meals were isocaloric.
Appetite ratings, glucose/insulin and gastrointestinal hormone responses were assessed either
at fasting and every 30' until 210' for GLP-1 and Oxyntomodulin and 240' for glucose and
insulin after the ingestion of the meal.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
Completed |
NCT01264523 -
Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients
|
N/A | |
Completed |
NCT03624803 -
DAPA - Egypt Study
|
||
Terminated |
NCT01787214 -
Walnuts and Glucose Variability
|
N/A | |
Completed |
NCT01715428 -
Liraglutide and Cardio-Metabolic Risk Markers
|
N/A | |
Completed |
NCT01884714 -
Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study
|
N/A | |
Completed |
NCT00567047 -
Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment
|
Phase 1 | |
Completed |
NCT02191644 -
Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes
|
Phase 2 | |
Completed |
NCT01440660 -
Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)
|
N/A | |
Completed |
NCT01343589 -
Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk
|
N/A | |
Completed |
NCT00651105 -
Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects
|
Phase 3 | |
Completed |
NCT04330911 -
The Effects of Aerobic Exercises on Exercise Capacity in Type-2 Diabetes Mellitus
|
N/A | |
Completed |
NCT03269058 -
Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04952948 -
Pilates Method on Functional Capacity and Blood Pressure of Elderly Women With Type 2 Diabetes
|
N/A | |
Completed |
NCT00478127 -
Hepatocyte Growth Factor and Cardiovascular Autonomic Function
|
N/A |